---
title: "Lux Capital: The NYC Firm Underwriting Frontier Science and Deep Tech at $4B AUM"
description: "Lux Capital backs companies where science and engineering outpace convention — quantum, biotech, defense, robotics. Here's how the NYC firm plays 2026."
date: 2026-04-18T00:00:00.000Z
tags: ["vc-explainers", "nyc-startups", "deep-tech", "venture-capital"]
source: https://venturecapitaltracker.com/nyc-lux-capital-deep-tech-frontier-science
---

# Lux Capital: The NYC Firm Underwriting Frontier Science and Deep Tech at $4B AUM

> Lux Capital backs companies where science and engineering outpace convention — quantum, biotech, defense, robotics. Here's how the NYC firm plays 2026.

**Lux Capital** is NYC's deep-tech standard bearer, managing ~$4B+ AUM and backing science-heavy startups across biotech, quantum, space, defense, and AI.

### Lux Capital's investment philosophy

- **Frontier over fashion**: Science-first, fashion-agnostic.
- **Long duration**: 10+ year hold patterns accepted.
- **Counter-conventional**: Lux routinely backs unconventional theses other firms pass on.
- **Writer partners**: Josh Wolfe's and Peter Hebert's public communication sets thesis direction.

### Notable Lux investments

- **Anduril** — defense tech giant.
- **Desktop Metal** — additive manufacturing.
- **Auris Health** — surgical robotics (acquired by JNJ for $3.4B).
- **Kallyope** — gut-brain biology.
- **Saildrone** — autonomous ocean vehicles.
- **Applied Intuition** — autonomy development software.
- **Latch** — smart buildings (public then delisted).
- **Planet Labs** — satellite imagery (public).
- **Clearpath / OTTO Motors** — robotics.
- **Recursion Pharmaceuticals** — AI drug discovery (public).

### Lux's 2026 thesis areas

1. **Defense tech** — aligned with Anduril thesis and broader dual-use investment surge.
2. **AI drug design** — extension of Recursion, Kallyope, and biotech bets.
3. **Quantum and compute** — hardware-software hybrid bets.
4. **Space and dual-use aerospace**.
5. **Bio x AI convergence** — foundation models for biology.

### What makes Lux unusual for NYC

- Most NYC firms lean SaaS, fintech, or media.
- Lux carries the city's strongest deep-tech bench, filling a gap that would otherwise mean losing deep-science founders to Bay Area firms.
- Supports broader NYC ecosystem credibility in hard tech.

### Practical takeaway

- **Founders**: Lux is a top choice for frontier-science startups that NYC generalists would reject.
- **Investors**: Lux portfolio is a leading indicator of sectors approaching inflection.
- **LPs**: Deep-tech exposure via Lux is a credible way to access the category from NYC.

### Sources

1. Lux Capital: https://www.luxcapital.com/
2. Ellenox NYC VC rankings: https://www.ellenox.com/post/new-york-city-venture-capital-firms

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.